322 related articles for article (PubMed ID: 29392460)
1. Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.
Avgerinos KI; Kalaitzidis G; Malli A; Kalaitzoglou D; Myserlis PG; Lioutas VA
J Neurol; 2018 Jul; 265(7):1497-1510. PubMed ID: 29392460
[TBL] [Abstract][Full Text] [Related]
2. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S
J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101
[TBL] [Abstract][Full Text] [Related]
3. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
[TBL] [Abstract][Full Text] [Related]
4. A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease.
Rosenbloom M; Barclay TR; Kashyap B; Hage L; O'Keefe LR; Svitak A; Pyle M; Frey W; Hanson LR
Drugs Aging; 2021 May; 38(5):407-415. PubMed ID: 33719017
[TBL] [Abstract][Full Text] [Related]
5. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.
Craft S; Raman R; Chow TW; Rafii MS; Sun CK; Rissman RA; Donohue MC; Brewer JB; Jenkins C; Harless K; Gessert D; Aisen PS
JAMA Neurol; 2020 Sep; 77(9):1099-1109. PubMed ID: 32568367
[TBL] [Abstract][Full Text] [Related]
6. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.
Claxton A; Baker LD; Wilkinson CW; Trittschuh EH; Chapman D; Watson GS; Cholerton B; Plymate SR; Arbuckle M; Craft S
J Alzheimers Dis; 2013; 35(4):789-97. PubMed ID: 23507773
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis.
Long C; Han X; Yang Y; Li T; Zhou Q; Chen Q
Front Aging Neurosci; 2022; 14():963933. PubMed ID: 36172480
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.
Muñoz-Jiménez M; Zaarkti A; García-Arnés JA; García-Casares N
Dement Geriatr Cogn Disord; 2020; 49(5):423-434. PubMed ID: 33080602
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Insulin for Alzheimer's Disease.
Hallschmid M
CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis.
Cao B; Rosenblat JD; Brietzke E; Park C; Lee Y; Musial N; Pan Z; Mansur RB; McIntyre RS
Diabetes Obes Metab; 2018 Oct; 20(10):2467-2471. PubMed ID: 29790638
[TBL] [Abstract][Full Text] [Related]
11. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
[TBL] [Abstract][Full Text] [Related]
13. Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs.
Avgerinos KI; Vrysis C; Chaitidis N; Kolotsiou K; Myserlis PG; Kapogiannis D
Neurol Sci; 2020 Oct; 41(10):2747-2754. PubMed ID: 32445136
[TBL] [Abstract][Full Text] [Related]
14. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
Park JH; Park H; Sohn SW; Kim S; Park KW
Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
[TBL] [Abstract][Full Text] [Related]
15. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E for Alzheimer's disease and mild cognitive impairment.
Isaac MG; Quinn R; Tabet N
Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
[TBL] [Abstract][Full Text] [Related]
17. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.
Reger MA; Watson GS; Green PS; Baker LD; Cholerton B; Fishel MA; Plymate SR; Cherrier MM; Schellenberg GD; Frey WH; Craft S
J Alzheimers Dis; 2008 Apr; 13(3):323-31. PubMed ID: 18430999
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Intranasal Insulin in Improving Cognition in Mild Cognitive Impairment and Alzheimer Disease: A Systematic Review and Meta-analysis.
Lu J; Xu Z
Am J Ther; 2019; 26(6):e756-e762. PubMed ID: 30648990
[No Abstract] [Full Text] [Related]
19. [The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review].
Ishmuratova AN; Abramov MA; Kuznetsov KO; Ivanyuta MV; Shakirova ZF; Kitapova AI; Usmonov MD; Chernousova LM; Valeeva LI; Kuznetsova AY; Baislamov AS; Shaihetdinova AR; Mirgaliev AA; Orozberdiev ST; Yakupova KI
Probl Endokrinol (Mosk); 2023 Nov; 69(5):73-83. PubMed ID: 37968954
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
